首页> 外国专利> DRUG FOR RETINAL DEGENERATIVE DISEASE ASSOCIATED WITH PHOTORECEPTOR DEGENERATION

DRUG FOR RETINAL DEGENERATIVE DISEASE ASSOCIATED WITH PHOTORECEPTOR DEGENERATION

机译:与感光细胞变性相关的视网膜退行性疾病药物

摘要

An object of the present invention is to provide a medicine that can simply treat and/or prevent a retinal degenerative disease associated with photoreceptor degeneration, including retinitis pigmentosa. The solution is to provide an agent for treating and/or preventing a retinal degenerative disease associated with photoreceptor degeneration, containing a compound having a retinoic acid receptor agonistic activity (for example, tamibarotene, tamibarotene methyl ester, tamibarotene ethyl ester, tazarotene, tazarotenic acid, adapalene, palovarotene, retinol, isotretinoin, alitretinoin, etretinate, acitretin or bexarotene) or a salt thereof.
机译:本发明的目的是提供一种可以简单地治疗和/或预防与光感受器变性有关的视网膜变性疾病的药物,包括色素性视网膜炎。该解决方案是提供一种用于治疗和/或预防与光感受器变性有关的视网膜变性疾病的试剂,其包含具有视黄酸受体激动活性的化合物(例如,他米巴罗汀,他米巴罗汀甲酯,他米巴罗汀乙酯,他扎罗汀,他扎罗汀酸) ,阿达帕林,palovarotene,视黄醇,异维A酸,铝维A酸,维A酸,阿维A或贝沙罗丁)或其盐。

著录项

  • 公开/公告号US2020330415A1

    专利类型

  • 公开/公告日2020-10-22

    原文格式PDF

  • 申请/专利权人 DAIICHI SANKYO COMPANY LIMITED;

    申请/专利号US201816628232

  • 发明设计人 NAOKI TSUJI;MASUMI UENO;

    申请日2018-07-03

  • 分类号A61K31/196;A61K9;A61P27/02;C12N5/079;G01N33/50;A61K31/24;A01K67/027;A61K49;A61K31/4436;A61K31/192;A61K31/415;

  • 国家 US

  • 入库时间 2022-08-21 11:25:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号